Harish Santhanam is the Vice President of Cell Therapy Technical Operations at Bristol Myers Squibb. Before joining BMS, he held roles of increasing responsibility at Eli Lilly, Merck, and Kite. At Kite, he was the Head of Technical Operations, where he led the start-up, qualification, and validation of a cell therapy manufacturing facility. Harish holds a Bachelor’s Degree in Chemical Engineering from the University of Illinois and a Master of Business Administration (MBA) from the University of Chicago.